buthionine sulfoximine has been researched along with Bone Loss, Osteoclastic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomila, C; Kamel, S; Louvet, L; Massy, Z; Mazière, C; Mazière, JC | 1 |
| Chambers, TJ; Davies, JT; Fuller, K; Jagger, CJ; Kirstein, B; Lean, JM; Partington, GA; Urry, ZL | 1 |
| Chambers, TJ; Davies, JT; Jagger, CJ; Lean, JM | 1 |
3 other study(ies) available for buthionine sulfoximine and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Oxidized low density lipoprotein decreases Rankl-induced differentiation of osteoclasts by inhibition of Rankl signaling.
Topics: Acid Phosphatase; Animals; Bone Resorption; Buthionine Sulfoximine; Cell Differentiation; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Glutathione; Humans; Isoenzymes; Lipoproteins, LDL; Macrophages; MAP Kinase Kinase 4; Mice; Monocytes; NF-kappa B; NFATC Transcription Factors; Osteoclasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; RANK Ligand; Reactive Oxygen Species; Signal Transduction; Tartrate-Resistant Acid Phosphatase | 2009 |
A crucial role for thiol antioxidants in estrogen-deficiency bone loss.
Topics: Animals; Antimetabolites; Antioxidants; Bone Marrow Cells; Bone Resorption; Buthionine Sulfoximine; Cells, Cultured; Estradiol; Estrogens; Female; Femur; Glutathione; Glutathione Reductase; Mice; Osteoblasts; Ovariectomy; Rats; Rats, Wistar; Sulfhydryl Compounds; Thioredoxins | 2003 |
Tumor necrosis factor-alpha mediates osteopenia caused by depletion of antioxidants.
Topics: Animals; Antimetabolites; Antioxidants; Bone Diseases, Metabolic; Bone Resorption; Buthionine Sulfoximine; Estrogens; Glutathione; Mice; Mice, Inbred Strains; Mice, Knockout; Osteogenesis; Ovariectomy; Receptors, Tumor Necrosis Factor; Signal Transduction; Solubility; Sulfhydryl Compounds; Tumor Necrosis Factor-alpha | 2005 |